{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:36:11Z","timestamp":1788438971071,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the clinical performance of three commercially available anti-double-stranded DNA (dsDNA) antibody immunoassays in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared the reactivity and diagnostic accuracy of three commercially available anti-dsDNA antibody immunoassays (radioimmunoassay, chemiluminescence enzyme immunoassay, and fluorescence enzyme immunoassay). We evaluated how well the three anti-dsDNA antibody immunoassays reflected disease activity and individual organ involvement in systemic lupus erythematosus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three anti-dsDNA antibody immunoassays demonstrated moderate to substantial correlation and concordance, while some patients exhibited different reactivity because of assay principles and detection systems. The diagnostic accuracies of the three immunoassays were comparable based on the receiver operating characteristic analyses and optimal cutoff values. Among the three anti-dsDNA antibody immunoassays, a fully automated chemiluminescence enzyme immunoassay-specific detection system demonstrated high sensitivity that reflects disease activity. The combined results of the titers and positivity rates of the three anti-dsDNA antibody immunoassays showed that nephritis was significantly associated with the chemiluminescence enzyme immunoassay and arthritis with the radioimmunoassay, and weak or no associations with other organ involvement were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We confirmed that the clinical performances of the three dsDNA immunoassays are comparable. Our findings suggest that selecting an optimal anti-dsDNA immunoassay will be useful for clinical decision-making in systemic lupus erythematosus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roag018","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:46:29Z","timestamp":1772023589000},"page":"768-777","source":"Crossref","is-referenced-by-count":1,"title":["Clinical performance of three anti-dsDNA antibody immunoassays in systemic lupus erythematosus"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8151","authenticated-orcid":false,"given":"Kenichi","family":"Uto","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaichi","family":"Okano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhide","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Kobe Tokiwa University , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saegusa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-341X","authenticated-orcid":false,"given":"Sho","family":"Sendo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital , Kobe, Hyogo ,","place":["Japan"]},{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine , Kobe, Hyogo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"2026083106415634400_ref1","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet."},{"key":"2026083106415634400_ref2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies \u2013 quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2026083106415634400_ref3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/kem112","article-title":"Rahman a fifty years of anti-ds DNA antibodies: are we approaching journey\u2019s end?","volume":"46","author":"Isenberg","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106415634400_ref4","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus \u2013 a proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026083106415634400_ref5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2018.05.014","article-title":"The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination","volume":"459","author":"Mummert","year":"2018","journal-title":"J Immunol Methods"},{"key":"2026083106415634400_ref6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2021.12.029","article-title":"Laboratory evaluation of anti-dsDNA antibodies","volume":"528","author":"Cockx","year":"2022","journal-title":"Clin Chim Acta"},{"key":"2026083106415634400_ref7","first-page":"1785","article-title":"Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"2026083106415634400_ref8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.cca.2010.03.016","article-title":"Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus","volume":"411","author":"Launay","year":"2010","journal-title":"Clin Chim Acta"},{"key":"2026083106415634400_ref9","first-page":"50","article-title":"Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study","volume":"29","author":"Ghirardello","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2026083106415634400_ref10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0022-1759(82)90096-5","article-title":"Influence of pH on the detection of low- and high-avidity anti-dsDNA","volume":"55","author":"Smeenk","year":"1982","journal-title":"J Immunol Methods"},{"key":"2026083106415634400_ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-1759(88)90438-3","article-title":"Dissociation studies of DNA\/anti-DNA complexes in relation to anti-DNA avidity","volume":"109","author":"Smeenk","year":"1988","journal-title":"J Immunol Methods"},{"key":"2026083106415634400_ref12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s10067-013-2330-3","article-title":"Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity","volume":"32","author":"Andrejevic","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2026083106415634400_ref13","doi-asserted-by":"crossref","first-page":"e000007","DOI":"10.1136\/lupus-2013-000007","article-title":"Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study","volume":"1","author":"Compagno","year":"2014","journal-title":"Lupus Sci Med"},{"key":"2026083106415634400_ref14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/jcm12041295","article-title":"Anti-dsDNA B-cell ELISpot as a monitoring and flare prediction tool in SLE patients","volume":"12","author":"P\u00e9rez-Isidro","year":"2023","journal-title":"J Clin Med"},{"key":"2026083106415634400_ref15","doi-asserted-by":"crossref","first-page":"328078","DOI":"10.1155\/2015\/328078","article-title":"Systemic lupus erythematosus with and without anti-dsDNA antibodies: analysis from a large monocentric cohort","volume":"2015","author":"Conti","year":"2015","journal-title":"Mediat Inflamm"},{"key":"2026083106415634400_ref16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2169\/internalmedicine.9613-22","article-title":"Severe lupus myocarditis preceded by mesalazine-induced lupus","volume":"62","author":"Yamashita","year":"2023","journal-title":"Intern Med"},{"key":"2026083106415634400_ref17","doi-asserted-by":"crossref","first-page":"e000984","DOI":"10.1136\/lupus-2023-000984","article-title":"Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: does a gold standard dsDNA assay exist?","volume":"10","author":"Trujillo Aguilera","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2026083106415634400_ref18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026083106415634400_ref19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026083106415634400_ref20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026083106415634400_ref21","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026083106415634400_ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026083106415634400_ref23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2026083106415634400_ref24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2026083106415634400_ref25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2026083106415634400_ref26","doi-asserted-by":"crossref","first-page":"e71458","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"},{"key":"2026083106415634400_ref27","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2665-9913(22)00332-0","article-title":"Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial","volume":"5","author":"Shipa","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026083106415634400_ref28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2026083106415634400_ref29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology."},{"key":"2026083106415634400_ref30","doi-asserted-by":"crossref","first-page":"1305865","DOI":"10.3389\/fimmu.2023.1305865","article-title":"Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus","volume":"14","author":"Bauer","year":"2023","journal-title":"Front Immunol"},{"key":"2026083106415634400_ref31","doi-asserted-by":"crossref","first-page":"102943","DOI":"10.1016\/j.autrev.2021.102943","article-title":"Systematic review of anti-dsDNA testing for systemic lupus erythematosus: a meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay","volume":"20","author":"Orme","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2026083106415634400_ref32","doi-asserted-by":"crossref","first-page":"kew462","DOI":"10.1093\/rheumatology\/kew462","article-title":"Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease","volume":"56","author":"Leeuw","year":"2017","journal-title":"Rheumatol (Oxf Engl)"},{"key":"2026083106415634400_ref33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/0961203313500368","article-title":"Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE","volume":"22","author":"Hillebrand","year":"2013","journal-title":"Lupus."},{"key":"2026083106415634400_ref34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10067-017-3771-x","article-title":"The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients","volume":"37","author":"Zhao","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2026083106415634400_ref35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0961203316640917","article-title":"International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies","volume":"25","author":"Bentow","year":"2016","journal-title":"Lupus."}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag018\/67153723\/roag018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/768\/67153723\/roag018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/768\/67153723\/roag018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:08Z","timestamp":1788172928000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/36\/5\/768\/8500980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roag018","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,2,27]]}}}